Literature DB >> 581533

Case report. Simultaneous fungal and viral infection of the central nervous system.

S Weitzman, S Kaufman, E Wolpow, R C Hinton, E P Richardson.   

Abstract

A patient with lymphoma developed central nervous system dysfunction and the diagnosis of cryptococcal meningitis was made. Because of discordant clinical and laboratory responses to appropriate treatment, further investigations were performed and the additional diagnosis of progressive multifocal leukoencephalopathy (PML) was established. Computerized axial tomography (CT scanning) proved helpful in pointing toward the latter disorder. Clinical, neuropathological, and microbiologic features are presented. The diagnostic approach to central nervous system illness in patients with impaired immunocompetence should include consideration of simultaneous infection with multiple agents.

Entities:  

Mesh:

Year:  1978        PMID: 581533     DOI: 10.1097/00000441-197807000-00014

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  4 in total

1.  Natalizumab in the treatment of multiple sclerosis.

Authors:  Ozgür Yaldizli; Norman Putzki
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

2.  Immunoadjuvant effect of inactivated Cryptococcus neoformans.

Authors:  Z Hubálek
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

3.  Immune Reconstitution Inflammatory Syndrome Secondary to Autoimmune Hemolytic Anemia and Cryptococcal Meningitis.

Authors:  SiJia Yin; Yan Xu; Jinsha Huang; Nian Xiong; Chao Han; Kai Ma; Xing Fang Guo; Yun Xia; Fang Wan; Liang Kou; Yadi Sun; Jiawei Wu; Tao Wang
Journal:  Front Neurol       Date:  2019-08-06       Impact factor: 4.003

4.  Simultaneous Development of Progressive Multifocal Leukoencephalopathy and Cryptococcal Meningitis during Methotrexate and Infliximab Treatment.

Authors:  Yasunobu Nosaki; Ken Ohyama; Maki Watanabe; Takamasa Yokoi; Kazuo Nakamichi; Masayuki Saijo; Yoshiharu Miura; Katsushige Iwai
Journal:  Intern Med       Date:  2019-09-15       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.